Medium-chain Acyl-coa Dehydrogenase Deficiency
📧 Sign up to get email alerts when something new happens for Medium-chain Acyl-coa Dehydrogenase Deficiency.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Study of Triheptanoin for the Prevention of Hypoglycemia in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD) [Phase 2]
A Phase 2 study of triheptanoin to prevent hypoglycemia in patients with Medium-chain acyl-CoA dehydrogenase deficiency has been suspended.
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: High Intensity Exercise in Children With MCADD [NA]
A clinical trial evaluating high-intensity exercise in children with Medium-chain acyl-CoA dehydrogenase deficiency has completed. The snipp…
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD) [Phase 2]
A Phase 2 clinical trial evaluating ACER-001 (sodium phenylbutyrate) for Medium-chain Acyl-CoA Dehydrogenase Deficiency has been suspended.
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Fatty Acid Oxidation Defects and Insulin Sensitivity [NA]
Clinical trial update reporting completed study on fatty acid oxidation defects and insulin sensitivity with posted results.
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Use of Ravicti™ in Patients With MCAD Deficiency With the 985A>G (K304E) Mutation [Phase 1]
Phase 1 trial update evaluating Ravicti in patients with MCAD deficiency carrying the 985A>G (K304E) mutation has completed with results pos…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.